Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2026-04-04 @ 2:08 PM
Study NCT ID:
NCT01767857
Status:
TERMINATED
Last Update Posted:
2021-06-29
First Post:
2013-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-08
First Submit QC Date:
None
Study First Post Date:
2013-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-04-22
Results First Submit QC Date:
None
Results First Post Date:
2021-06-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-28
Last Update Post Date:
2021-06-29
Last Update Post Date Type:
ACTUAL